Navigation Links
NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
Date:5/7/2008

ilto:jruddock@nektar.com">jruddock@nektar.com

1 Handel K, Schauben J, Salmone F, Naloxone. Annals of Emergency

Medicine 1993; 12.7; 438-51

2 Kalso et al., Opioids in chronic non-cancer pain; systematic review of

efficacy and safety.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
2. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
3. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
4. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
5. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
6. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
7. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
8. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
9. Preclinical Study Shows CTIs Brostallicins Cancer-Killing Ability Based on Genetic Profiling
10. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
11. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2008)... Nation,s Largest Renal Research Network Comple...34 Active Trials in Late Stage Development, EL SE...al Research(R),(DCR), a Phase I-IV clinical trial ...lated drug and device research and development for...nical trials in 2007 and has another 34,active tri...
(Date:5/8/2008)... VYVANSE demonstrated significant improvement in...wswire-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq: ...pany, today,presented the results of a phase III p...cant improvements in Attention Deficit Hyperactivi...safety and efficacy,endpoints., "Adults with ADHD...
(Date:5/8/2008)... Treatment Provides "Blueprint" to Produce The...HTS, Ill., May 8 /PRNewswire-USNewswire/ -- Using ...er fighting proteins through,skin flaps placed on ...on,in tumor volume, according to a study in the Ma...the official medical journal of the American,Socie...
(Date:5/8/2008)... - Memorial Sloan-Kettering Cancer Center Invest...A-Negative Ovarian Cancer Patients -, BRISBANE, C...today,announced the expansion of Phase 2 clinical ...varian cancer. This is the third major clinical tr... 6 months, expanding on,on-going trials in breast ...
Breaking Medicine Technology:DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2New study 3A Pine bark reduces perimenopausal symptoms 215 1New study 3A Pine bark reduces perimenopausal symptoms 215 2Thermo Fisher Scientific to Present at Investor Conferences 220 1Thermo Fisher Scientific to Present at Investor Conferences 220 2GenVault Partnership with Genome Quebec Brings 243 3 Million Sale of Dynamic Archive Product 216 1GenVault Partnership with Genome Quebec Brings 243 3 Million Sale of Dynamic Archive Product 216 2GenVault Partnership with Genome Quebec Brings 243 3 Million Sale of Dynamic Archive Product 216 3GenVault Partnership with Genome Quebec Brings 243 3 Million Sale of Dynamic Archive Product 216 4Alcoholics With Cirrhosis Have More Brain Damage 213 1Alcoholics With Cirrhosis Have More Brain Damage 213 2
...ay 15, 2007 - Gemin X Biotechnologies,Inc. announc...ood,demonstrated that its lead compound, obatoclax... Cell Lymphoma (MCL) cell lines and,primary cells ...all,molecule specifically designed to inhibit all ...lidated cancer target, thus restoring,the natural ...
... , LONDON, UK and ATLANTA, US, May 14, 2007 - Skye...a. Inc. (NASDAQ:SCRX) today,announce the successfu...he new formulation of Sular, a calcium ,channel bl...ure.,The study results showed that the new Sular f...marketed Sular. The new,Sular formulation utilize...
Other Medicine Technology:Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 2SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 3
(Date:5/11/2008)...LPHIA, May 11 /PRNewswire/ -- As the global commun...d,s second most deadly cyclone of all,time and the...nitarian aid,for cyclone victims, the Alumni Myanm...been proactive-and more importantly, successful-in...ea of Myanmar where 100,000 people,are assumed dea...
(Date:5/11/2008)...eds of thousands of homeless forced to migrate nor...le so far with water, rice, survival ... /PRNewswire-FirstCall/ -- The lives of,thousands ... scramble out,of the shattered Irrawaddy Delta to ...sment of 26 shelters across the Myaung Mya region ...
(Date:5/11/2008)... can be bought over the counter and safely used at...) -- When you,re doing your spring cleaning, don,t...p and easy way for people with spring allergies, n...to get relief, says Dr. Melissa Pynnonen, co-direc...professor in the University of Michigan,s departme...
(Date:5/10/2008)...os need to play smart to avoid devastating vision ...0 (HealthDay News) -- Every year in the United Sta... injuries, says the American Academy of Ophthalmol... appropriate, sports-specific eye protection prope...s made from polycarbonate materials offer the high...
Breaking Medicine News(10 mins):Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2Health News:Crisis in Myanmar Relief Camps: Mass Exodus Sets Stage for Public Health Emergency 2Health News:Nasal Irrigation Can Help Fight Spring Allergies 2Health News:Protective Eyewear Key to Sports Safety 2
...speridone) an antipsychotic drug has been for the...ed for symptomatic treatment of emotional disturba...tism, by The U.S. Food and Drug Administration. ...ed in the treatment of adults, Risperidone will th...
...illiams syndrome, a rare genetic disorder, just lo...ng music. Despite averaging an IQ score of 60, man...ense of rhythm, and the kind of auditory acuity, t...fferent vacuum cleaner brands. A study by a multi-...
...e evaluation of the situation, the Union Health Mi...chikungunya- affected areas in Kerala’s Alapuzha d... in the past 3 weeks has been reported from Cherth...als in this area.Experts from WHO and national ins...
...recent research, drinking cola can lead to brittle...the more of the carbonated drink women consumed, t...ned with development of osteoporosis are advised n...oric acid, present in cola and not in several othe...
Other Medicine News:Health News:Williams Syndrome, the Brain, and Music 2Health News:Williams Syndrome, the Brain, and Music 3Health News:Williams Syndrome, the Brain, and Music 4Health News:Cola increases risk of Osteoporosis!! 2
One piece, 100% fused silica construction offers low scatter and high efficiency
The Ultrafin™ Stirrup is the latest in bariatric lithotomy positioing. This stirrup features a roomier boot for larger calves and accommodates up to an 800 pound weight range. Piston technology
The new series of Steris Power-lift Stirrups incorporate all of the proven clinical benefits of Allen-style booted stirrups: maximum safety for the patient, ease of setup for your staff, impressive v
Designed for Bariatric usage. Prevents arm or leg dropout during surgical procedures. Dimensions are 16"Lx10"H come in pairs. Optional gel pad available (BD2245)
Medicine Products: